Thomas has been serial entrepreneur for more than 30 years, 25 of which across the entire Life Sciences value chain. A relentless enthusiast by nature, he consistently dreams big, aims high and innovates across boundaries. He has taken many healthcare products and businesses from ideation all the way to the market, as well as subsequent successful divestiture and now heads up Neem Biotech as an innovation and incubation engine for an ever growing portfolio of groundbreaking therapeutic solutions. Shepherding game-changing opportunities that change world health for the better in unique ways is a lifelong dream come true for Thomas. It’s the perfect set-up for someone who dreams as big as he does.
My vision has always been to create a better world by enabling people through improving their health and education. My professional path started in banking: arranging financing for large infrastructural projects in developing countries. Years of professional experience helped me lay the strong ground work for my current activities. I am proud to say that I never lost sight of my original goals. They made who I am and what I do today: Founder and Chairman of the Zaluvida Group. Our cutting-edge research into finding solutions for today’s big challenges to the health of mankind and our philanthropic activities, supporting education and life-improving opportunities for the disadvantaged and their communities, are taking us into the realm of amazing possibilities.
Dr Dixon has spent over 25 years in Big Pharma, VC funded and publicly listed biotechnology companies. He held CSO and COO roles in Onxeo, Sensorion, Addex Therapeutics, Galapagos, Entomed and F2G where he led over ten positive proof of concept programmes in humans and was part of several new drug approval programmes. He has been involved in raising substantial investment for these programmes over this period.